Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by juniper88on Oct 27, 2019 9:10pm

80 Views

Post# 30274992

RE:RE:RE:RE:RE:RE:Article on Thera in Les Affaires

I agree that better/transparent communication by luc and Thera could have avoided some of the SP pain we are feeling now and could have forced the analyst to write more realistic reports.

palinc2000 wrote: Nope I am not blaming Luc for the lack of interest from US investors.I think its too early to tell if any US analysts will jup on Board and ieven if the Presentation went well getting new in depth coverage on TH by a major US analyst wpould take weeks at least if not mos.
I am referring to Luc blaming CDB analysts for not supporting TH .......Luc is putting blame atthe wrong place....He needs to look in the mirror ...Just read my many posts where I explain how Luc is responsible for the CDN analysts and the CDN market having such high expectations on Trogarzo ..Now Luc seems to be hinting that CDN analysts have no brain ,,,,,,That really ticks me off coming from him....Work on your sales Luc ,work on your business ,try to regain some credibility

juniper88 wrote:

palinc2000 wrote: CEOs get the analysts they deserve!!!
I have never heard a successful CEO complain about analysts coverage.

First, define successful. If it is a high/rising share price then why would a CEO complain about analysts? A bit of a catch 22 I think. I and others here seem to believe the R&D day went well. Some had suggested the U.S. investors would not buy in until after the R&D day, but the reality is that this "catalyst" has come and gone and the U.S. investors just shrugged their shoulders. Luc performance might not have been great but I don't think you can blame him for the lack of interest by the U.S investors.